1. |
刘利, 田攀文. 生物标志物在肺癌筛查中的研究进展. 华西医学, 2020, 35(1): 78-83.
|
2. |
Hu X, Li C, Chen J, et al. Confidence intervals for the Youden index and its optimal cut-off point in the presence of covariates. J Biopharm Stat, 2021, 31(3): 251-272.
|
3. |
李太顺, 刘沛. ROC曲线绘制和曲线下面积比较的SAS宏包. 中国卫生统计, 2018, 35(2): 302-304,309.
|
4. |
Muschelli J. ROC and AUC with a binary predictor: a potentially misleading metric. J Classif, 2020, 37(3): 696-708.
|
5. |
Wang Z, Zhou X. Biomarker assessment and combination with differential covariate effects and an unknown gold standard, with an application to Alzheimer’s disease. Ann Appl Stat, 2018, 12(2): 1204-1227.
|
6. |
Janes H, Pepe MS. Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidemiol, 2008, 168(1): 89-97.
|
7. |
Le Borgne F, Combescure C, Gillaizeau F, et al. Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors. Stat Methods Med Res, 2018, 27(11): 3397-3410.
|
8. |
王茹月, 叶雨. PSA衍生指标诊断前列腺癌的研究进展. 中华男科学杂志, 2019, 25(7): 655-659.
|
9. |
Liu Y, Xiao G, Zhou JW, et al. Optimal starting age and baseline level for repeat tests: economic concerns of psa screening for chinese men - 10-year experience of a single center. Urol Int, 2020, 104(3-4): 230-238.
|
10. |
Janes H, Pepe MS. Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve. Biometrika, 2009, 96(2): 371-382.
|
11. |
Janes H, Longton G, Pepe M. Accommodating covariates in ROC analysis. Stat J, 2009, 9(1): 17-39.
|
12. |
Inácio V, M Lourenço V, de Carvalho M, et al. Robust and flexible inference for the covariate-specific receiver operating characteristic curve. Stat Med, 2021, 40(26): 5779-5795.
|
13. |
Pepe M, Longton G, Janes H. Estimation and comparison of receiver operating characteristic curves. Stata J, 2009, 9(1): 1.
|
14. |
Anoke SC, Normand SL, Zigler CM. Approaches to treatment effect heterogeneity in the presence of confounding. Stat Med, 2019, 38(15): 2797-2815.
|
15. |
Wu Z, Chen Q, Djaladat H, et al. A preoperative nomogram to predict renal function insufficiency for cisplatin-based adjuvant chemotherapy following minimally invasive radical nephroureterectomy (ROBUUST collaborative group). Eur Urol Focus, 2022, 8(1): 173-181.
|
16. |
Momota M, Hatakeyama S, Tokui N, et al. The impact of preoperative severe renal insufficiency on poor postsurgical oncological prognosis in patients with urothelial carcinoma. Eur Urol Focus, 2019, 5(6): 1066-1073.
|
17. |
Rouer M, Monnot A, Bubenheim M, et al. Early postoperative renal dysfunction predicts long-term renal function degradation after type Ⅳ thoracoabdominal aortic aneurysm surgical repair. Ann Vasc Surg, 2020, 68: 316-325.
|
18. |
Cohen JS, Gu A, Wei C, et al. Preoperative estimated glomerular filtration rate is a marker for postoperative complications following revision total knee arthroplasty. J Arthroplasty, 2019, 34(4): 750-754.
|
19. |
Onohara T, Takagi T, Yoshida K, et al. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism. Int J Urol, 2019, 26(2): 229-233.
|
20. |
Oto J, Fernández-Pardo Á, Royo M, et al. A predictive model for prostate cancer incorporating PSA molecular forms and age. Sci Rep, 2020, 10(1): 2463.
|
21. |
Tao T, Shen D, Yuan L, et al. Establishing a novel prediction model for improving the positive rate of prostate biopsy. Transl Androl Urol, 2020, 9(2): 574-582.
|